Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Cardiol Clin. 2016 Aug;34(3):451–472. doi: 10.1016/j.ccl.2016.04.005

Figure 14.

Figure 14

Treatment algorithm proposed in the management of pediatric patients with idiopathic or heritable pulmonary arterial hypertension. This may be translatable to other patients with pulmonary hypertension. CCB, calcium channel blocker; ERA, endothelin receptor antagonist; PDE-5i, phosphodiesterase 5 inhibitor.

Adapted from Ivy DD, Abman SH, Barst RJ, et al. Pediatric pulmonary hypertension. J Am Coll Cardiol 2013;62(25 Suppl):D117–26; with permission.